BioQuest Corp.
Simbols: BQST
OTC
1.94
USDTirgus cena šodien
-6.6840
P/E koeficients
-0.0886
PEG koeficients
22.28M
MRK Cap
- 0.00%
DIV ienesīgums
BioQuest Corp. (BQST) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.net-receivables | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.other-current-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-current-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-non-current-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.account-payables | 0 | 0 | 0.2 | 0.2 | ||||||||
balance-sheet.row.short-term-debt | 0 | 0.2 | 0.2 | 0.1 | ||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 0 | 0.4 | 0.1 | 0.1 | ||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 0 | 0.4 | 0 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | -0.4 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-liab | 0 | 0.6 | 0.5 | 1.8 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.retained-earnings | 0 | -10.8 | -10.7 | -9.8 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0.1 | 0.2 | 0 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 10.1 | 10 | 8.1 | ||||||||
balance-sheet.row.total-stockholders-equity | 0 | -0.6 | -0.4 | -1.8 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 0 | -0.6 | -0.4 | -1.8 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||
Total Investments | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-debt | 0 | 0.2 | 0.2 | 0.1 | ||||||||
balance-sheet.row.net-debt | 0 | 0.2 | 0.1 | 0.1 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -0.1 | -0.8 | -2.3 | |||||||
cash-flows.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0.2 | 0.5 | |||||||
cash-flows.row.change-in-working-capital | 0 | 0 | 0.5 | 1.5 | |||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0.2 | |||||||
cash-flows.row.other-working-capital | 0 | 0 | 0.5 | 1.3 | |||||||
cash-flows.row.other-non-cash-items | 0 | 0.1 | -0.1 | 0.1 | |||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.debt-repayment | 0 | 0 | -0.1 | -0.1 | |||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0.1 | 0.1 | |||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.other-financing-activites | 0 | 0 | 0.2 | 0.1 | |||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 0 | 0.1 | 0.2 | |||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.net-change-in-cash | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.cash-at-end-of-period | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.operating-cash-flow | 0 | -0.1 | -0.1 | -0.2 | |||||||
cash-flows.row.capital-expenditure | 0 | 0 | 0 | 0 | |||||||
cash-flows.row.free-cash-flow | 0 | -0.1 | -0.1 | -0.2 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.cost-of-revenue | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.gross-profit | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.other-expenses | 0 | 0 | 0.2 | 0.5 | |||||||
income-statement-row.row.operating-expenses | 0 | 0 | 0.8 | 2.2 | |||||||
income-statement-row.row.cost-and-expenses | 0 | 0 | 0.8 | 2.2 | |||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.1 | 0 | |||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||
income-statement-row.row.total-other-income-expensenet | 0 | -0.1 | 0 | -0.1 | |||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0.2 | 0.5 | |||||||
income-statement-row.row.total-operating-expenses | 0 | -0.1 | 0 | -0.1 | |||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.1 | 0 | |||||||
income-statement-row.row.depreciation-and-amortization | 0 | 0 | 0 | 0 | |||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||
income-statement-row.row.operating-income | 0 | 0 | -0.8 | -2.2 | |||||||
income-statement-row.row.income-before-tax | 0 | -0.1 | -0.8 | -2.3 | |||||||
income-statement-row.row.income-tax-expense | 0 | 0 | -0.1 | 0 | |||||||
income-statement-row.row.net-income | 0 | -0.1 | -0.7 | -2.4 |
Biežāk uzdotie jautājumi
Kas ir BioQuest Corp. (BQST) kopējie aktīvi?
BioQuest Corp. (BQST) kopējie aktīvi ir 31.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.000.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir -0.002.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.000.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.000.
Kāda ir BioQuest Corp. (BQST) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir -140664.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 183300.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 49063.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.